Table 1.
|
DKD
|
NDKD
|
Ref.
|
Clinical characteristics | [57,71,72] | ||
Diabetic retinopathy | Microhematuria; active urinary sediment | ||
Longer diabetes duration (> 5 yr) | Acute onset of nephrotic proteinuria | ||
Acute kidney injury | |||
Positive autoimmunity | |||
Histopathological elements | [27,29] | ||
Light microscopy | |||
Diffuse glomerulosclerosis | Thickening of the GBM; mesangial expansion; mesangiolysis | Reduced vascular involvement and arteriolar hyalinosis | |
Nodular glomerulosclerosis | Mesangial expansion with nodular glomerular sclerosis (“Kimmelstiel-Wilson nodules”) | ||
Nodules are PAS-positive, silver and Congo red negative | Amyloidosis: Congo red positive staining | ||
Immunofluorescence | Linear staining of the GBM and tubular basement membrane for IgG and albumin; no other specific stainings | MIDD: Light-chain and/or heavy-chain deposits; IgAN: Predominant or codominant mesangial staining for IgA with or without C3; Cryoglobulinaemia and MPGN: Mesangial and GBM staining for IgM, IgG and C3 | |
Electron microscopy | Diffuse GBM thickening; diabetic fibrillosis; podocytopenia | Fibrillar and Immunotactoid glomerulonephritis: Microfibrillar and microtubules deposition; cryoglobulinaemia and MPGN: Mesangial, subendothelial and subepithelial electron-dense deposits, intracapillary thrombi and leucocytic infiltrate | |
Radiological features | Higher renal arterial resistance index (> 0.66) | [78] | |
Biomarkers | Higher uNGAL/creatinine ratio (cutoff = 60.85 ng/mg) | [75] | |
Omic sciences | Specific biomolecular signatures in urine and plasma; proteomic analysis of extracellular vesicles | [79,80,81,83] | |
Other techniques | Evaluation of urine samples by Raman spectroscopy and chemometric analysis | [82] |
DKD: Diabetic kidney disease; NDKD: Nondiabetic kidney disease; MIDD: Monoclonal immunoglobulin deposition disorder; IgAN: IgA nephropathy; GBM: Glomerular basal membrane; MPGN: Membranoproliferative glomerulonephritis; uNGAL: Urinary neutrophil gelatinase-associated lipocalin.